Concepedia
Statistics
Publications
8
Citations
307
H-Index
Active since
2008
Affiliations
National Cancer Institute(Current)
Center for Cancer Research
National University of Singapore
St. John's University
Sun Yat-sen University
Hong‐May Sim is an author at National Cancer Institute specializing in medicine, cancer pharmacology, and chemotherapy resistance.
Publications per year
2008–2014
Overexpression of ATP-binding cassette transporter ABCG2 as a potential mechanism of acquired resistance to vemurafenib in BRAF(V600E) mutant cancer cells
Chung‐Pu Wu, Hong‐May Sim, Yang-Hui Huang et al. · Biochemical Pharmacology · 2012 · 75 citations
Medicine, Molecular Biology, Oncology +15
Dimethoxyaurones: Potent inhibitors of ABCG2 (breast cancer resistance protein)
Hong‐May Sim, Chong Yew Lee, Pui Lai Rachel Ee et al. · European Journal of Pharmaceutical Sciences · 2008 · 73 citations
Medicine, Medicinal Chemistry, Pharmacology +12
Saracatinib (AZD0530) is a potent modulator of ABCB1‐mediated multidrug resistance<i>in vitro</i>and<i>in vivo</i>
Ke‐Jun Liu, Jie‐Hua He, Xiao‐Dong Su et al. · International Journal of Cancer · 2012 · 41 citations · Full text
Medicine, Oncology, Pharmacology +17
Human ABCB1 (P-glycoprotein) and ABCG2 mediate resistance to BI 2536, a potent and selective inhibitor of Polo-like kinase 1
Chung‐Pu Wu, Sung-Han Hsiao, Hong‐May Sim et al. · Biochemical Pharmacology · 2013 · 38 citations · Full text
Medicine, Medicinal Chemistry, Pharmacology +10
Synthesis and antimicrobial activity of N1-benzyl or N1-benzyloxy-1,6-dihydro-1,3,5-triazine-2,4-diamines
Xiang Ma, Soo-Tong Tan, Chai-Ling Khoo et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 30 citations · Full text
Medicine, Chemistry, Microbiology +9
1–5 of 8